Evidence map›Paper›PMID 31404118›Full record

ArticlePLoS pathogens2019

Transposon-insertion sequencing screens unveil requirements for EHEC growth and intestinal colonization.

Alyson R Warr, Troy P Hubbard, Diana Munera, Carlos J Blondel, Pia Abel Zur Wiesch, Sören Abel, Xiaoxue Wang, Brigid M Davis, Matthew K Waldor

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. EnterohemorrhagicmSystems · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Outer membrane barrier impairment byMicrobiology (Reading, England) · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Alyson R WarrDivision of Infectious Diseases, Brigham & Women's Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0002-1151-0108
Troy P HubbardDivision of Infectious Diseases, Brigham & Women's Hospital, Boston, Massachusetts, United States of America.
Diana MuneraDivision of Infectious Diseases, Brigham & Women's Hospital, Boston, Massachusetts, United States of America.
Carlos J BlondelDivision of Infectious Diseases, Brigham & Women's Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0002-7099-6347
Pia Abel Zur WieschDivision of Infectious Diseases, Brigham & Women's Hospital, Boston, Massachusetts, United States of America.
Sören AbelDivision of Infectious Diseases, Brigham & Women's Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0002-4041-6989
Xiaoxue WangDivision of Infectious Diseases, Brigham & Women's Hospital, Boston, Massachusetts, United States of America.
Brigid M DavisDivision of Infectious Diseases, Brigham & Women's Hospital, Boston, Massachusetts, United States of America.
Matthew K WaldorDivision of Infectious Diseases, Brigham & Women's Hospital, Boston, Massachusetts, United States of America.
Brigham and Women's Hospital · US

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JONATHAN C KAGAN · 1986 to 2026
$32.4M
Vibrio cholerae intestinal colonization and vaccine developmentR01AI042347 · NIAID · TUFTS UNIVERSITY BOSTON · PI WALDOR, MATTHEW K · 1998 to 2025
$7.3M
Bacteriology PhD Training ProgramT32AI132120 · NIAID · HARVARD MEDICAL SCHOOL · PI RUDNER, DAVID Z · 2017 to 2021
$1.7M
Genetic Analysis of Vibrio parahaemolyticus PathogenicityF31AI120665 · NIAID · HARVARD MEDICAL SCHOOL · PI HUBBARD, TROY PATRICK · 2015 to 2017
$96k
Howard Hughes Medical InstituteNIAID NIH HHS F31 AI120665NIAID NIH HHS R01 AI042347NIAID NIH HHS T32 AI132120NIDDK NIH HHS P30 DK034854
6 · The paper itself

Abstract

Enterohemorrhagic Escherichia coli O157:H7 (EHEC) is an important food-borne pathogen that colonizes the colon. Transposon-insertion sequencing (TIS) was used to identify genes required for EHEC and E. coli K-12 growth in vitro and for EHEC growth in vivo in the infant rabbit colon. Surprisingly, many conserved loci contribute to EHEC's but not to K-12's growth in vitro. There was a restrictive bottleneck for EHEC colonization of the rabbit colon, which complicated identification of EHEC genes facilitating growth in vivo. Both a refined version of an existing analytic framework as well as PCA-based analysis were used to compensate for the effects of the infection bottleneck. These analyses confirmed that the EHEC LEE-encoded type III secretion apparatus is required for growth in vivo and revealed that only a few effectors are critical for in vivo fitness. Over 200 mutants not previously associated with EHEC survival/growth in vivo also appeared attenuated in vivo, and a subset of these putative in vivo fitness factors were validated. Some were found to contribute to efficient type-three secretion while others, including tatABC, oxyR, envC, acrAB, and cvpA, promote EHEC resistance to host-derived stresses. cvpA is also required for intestinal growth of several other enteric pathogens, and proved to be required for EHEC, Vibrio cholerae and Vibrio parahaemolyticus resistance to the bile salt deoxycholate, highlighting the important role of this previously uncharacterized protein in pathogen survival. Collectively, our findings provide a comprehensive framework for understanding EHEC growth in the intestine.

Indexed as

DNA Transposable ElementsAnimalsEscherichia coli InfectionsEscherichia coli O157Escherichia coli ProteinsGene Expression Regulation, BacterialIntestinesRabbitsSequence Analysis, DNAVirulence FactorsDNA Transposable ElementsEscherichia coli ProteinsVirulence Factors

Identifiers

PMID31404118
PMCPMC6705877
OpenAlexW2968986150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.